Omega Alpha SPAC (Omega Alpha SPAC) Cash, Cash Equivalents, Marketable Securities : $0.15 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Omega Alpha SPAC Cash, Cash Equivalents, Marketable Securities?

Omega Alpha SPAC's quarterly cash, cash equivalents, marketable securities declined from Mar. 2022 ($0.34 Mil) to Jun. 2022 ($0.20 Mil) but then stayed the same from Jun. 2022 ($0.20 Mil) to Sep. 2022 ($0.15 Mil).

Omega Alpha SPAC's annual cash, cash equivalents, marketable securities stayed the same from . 20 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) but then increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.52 Mil).

Omega Alpha SPAC Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Omega Alpha SPAC's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omega Alpha SPAC Cash, Cash Equivalents, Marketable Securities Chart

Omega Alpha SPAC Annual Data

Trend

Dec20

Dec21

Cash, Cash Equivalents, Marketable Securities

0.52

Omega Alpha SPAC Quarterly Data
	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial			0.64	0.52	0.34	0.20	0.15

Omega Alpha SPAC Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Omega Alpha SPAC (NAS:OMEG) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Omega Alpha SPAC Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Omega Alpha SPAC's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Omega Alpha SPAC (Omega Alpha SPAC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Omega Alpha SPAC (NAS:OMEG) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

888 Boylston Street, Suite 1111, Boston, MA, USA, 02199

Website

Omega Alpha SPAC is a blank check company.

Executives

Otello Stampacchia	director, 10 percent owner, officer: Chief Executive Officer	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Alpha Management Omega	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02119
Joseph P Slattery	director	C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Martin Babler	director	C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Daniel Lynch	director
Vincent Ossipow	officer: Chief Scientific Officer	CH. DES VIGNES 1, COMMUGNY V8 1291
Van De Winkel Jan	director	C/O HOOKIPA PHARMA INC., 430 EAST 29TH STREET 14TH FLOOR, NEW YORK NY 10016
Omega Fund Vi, L.p.	10 percent owner	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp Manager, Ltd.	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp, L.p.	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Michelle Doig	director, officer: President	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Francesco Draetta	officer: Chief Financial Officer	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Alexandra Pearsall	10 percent owner	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199

Omega Alpha SPAC (Omega Alpha SPAC) Headlines

From GuruFocus

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

By Business Wire Business Wire • 01-07-2021

Omega Alpha Spac (OMEG) CEO Otello Stampacchia Bought $5 million of Shares

By GuruFocus Research GuruFocus Editor • 01-14-2021